HIGHLIGHTS
- who: IRGRS and collaborators from the LMU Munich University Hospital, Germany have published the article: Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients, in the Journal: (JOURNAL)
- what: The authors focused on the distribution of Frontiers in Genetics frontiersin.org 10.3389/fgene.2022.1011390 from immunotherapy than low-IRGRS patients . More importantly, the study has developed several new insights for bladder cancer immunotherapy that target the IRGRS phenotype and immune phenotype.
- how: The authors conducted K-M survival analysis to choose the genes associated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.